Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01855022
Recruitment Status : Completed
First Posted : May 16, 2013
Last Update Posted : May 16, 2013
Health Resources and Services Administration (HRSA)
Information provided by (Responsible Party):
Ariel Linden, DrPH, Asante Health System

Brief Summary:
The primary purpose of this study is to determine the effectiveness of a hospital-based intervention, using motivational interviewing and interactive voice response (IVR), to reduce hospital readmissions within 90 days of enrollment compared to usual care, for patients with heart failure and chronic obstructive pulmonary disease.

Condition or disease Intervention/treatment Phase
Congestive Heart Failure (CHF) Chronic Obstructive Pulmonary Disease (COPD) Behavioral: MI + IVR Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 512 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: A Hospital-based Intervention Using Motivational Interviewing and Interactive Voice Response to Reduce Readmissions in Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial
Study Start Date : June 2010
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Heart Failure

Arm Intervention/treatment
Experimental: MI + IVR
90 days of motivational interviewing and 30 days of interactive voice response monitoring
Behavioral: MI + IVR
Participants in the intervention group received motivational interviewing from a registered nurse who is trained and proficient in this behavioral change modality. In addition, participants were instructed to make a daily toll-free call to an automated interactive voice response (IVR) system provided by Pharos Innovations® (Chicago, IL) for 30 days after discharge from the index admission. On each call patients heard a pre-recorded voice that goes through a series of questions about symptoms and the patient's daily weight. Information from the IVR system was automatically downloaded to a secure Internet site for review by the nurse at each hospital location.

No Intervention: Usual Care
Usual care that a patient would receive absent the intervention

Primary Outcome Measures :
  1. Hospital readmission rate (all cause) [ Time Frame: 90 days ]
    Readmissions within 90 days from discharge of the index admission, for any diagnosis

Secondary Outcome Measures :
  1. Emergency department visit rate (all cause) [ Time Frame: 90 days ]
    Visits to the emergency department within 90 days from discharge of the index admission, for any diagnosis

  2. Hospital days (all cause) [ Time Frame: 90 days ]
    The total number of hospitals days for those readmissions occurring in the 90 day period after discharge of the index admission

  3. Mortality [ Time Frame: 90 days ]
    Deaths occurring within 90 days of discharge of the index admission

  4. Patient Activation Measure (PAM) score [ Time Frame: 90 days ]
    Patient Activation Measure (PAM) score at 30 and 90 days post discharge of the index admission

Other Outcome Measures:
  1. Days compliant with interactive voice response system (treatment group only) [ Time Frame: 30 days ]
    The average number of days that treatment group participants engaged with the interactive voice response system

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 years or older
  • Index hospitalization for congestive heart failure or chronic obstructive pulmonary disease
  • Access to telephone

Exclusion Criteria:

  • Cognitive impairment
  • Resident of a nursing home
  • Does not speak English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01855022

Layout table for location information
United States, Oregon
Asante Three Rivers Medical Center
Grants Pass, Oregon, United States, 97527
Asante Rogue Regional Medical Center
Medford, Oregon, United States, 97504
Sponsors and Collaborators
Asante Health System
Health Resources and Services Administration (HRSA)
Layout table for investigator information
Principal Investigator: Ariel Linden, DrPH Linden Consulting Group, LLC
Study Director: Debra Flickinger, BS Asante Health System
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ariel Linden, DrPH, President, Linden Consulting Group, LLC, Asante Health System Identifier: NCT01855022    
Other Study ID Numbers: H2AIT16621-B
First Posted: May 16, 2013    Key Record Dates
Last Update Posted: May 16, 2013
Last Verified: May 2013
Keywords provided by Ariel Linden, DrPH, Asante Health System:
Motivational interviewing
Interactive voice response
Hospital readmission
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Heart Failure
Heart Diseases
Cardiovascular Diseases
Respiratory Tract Diseases